Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1979 1
1985 1
1988 1
1989 2
1990 1
1991 1
1992 1
1993 1
1994 1
1995 3
1996 1
1997 1
1998 4
2000 1
2001 3
2002 3
2003 3
2004 4
2005 3
2006 5
2007 5
2008 4
2009 6
2010 5
2011 1
2013 2
2014 2
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 21378359

64 results
Results by year
Filters applied: . Clear all
Page 1
A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
Serretta V, Morgia G, Altieri V, Di Lallo A, Ruggiero G, Salzano L, Battaglia M, Falsaperla M, Zito A, Sblendorio D, Melloni D, Allegro R; members of Gruppo Studi Tumori Urologici (GSTU) Foundation. Serretta V, et al. BJU Int. 2010 Jul;106(2):212-7. doi: 10.1111/j.1464-410X.2009.09153.x. Epub 2010 Jan 11. BJU Int. 2010. PMID: 20070299 Clinical Trial.
Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H. Friedrich MG, et al. Eur Urol. 2007 Oct;52(4):1123-29. doi: 10.1016/j.eururo.2007.02.063. Epub 2007 Mar 12. Eur Urol. 2007. PMID: 17383080 Clinical Trial.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page